<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">This case suggests that there is a possibility of interstitial lung disease developing in patients undergoing hepatitis C treatment. Pharmacists should try to collect adverse effect reports for early identification of adverse effects. Pharmaceutical companies should also provide adverse effect information as soon as possible.</p>
